TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22285123

Group type: EXPERIMENTAL
Intervention: GIK infusion (500 mL of dextrose in water (DW) 10% + 40 U of regular insulin + 40 mEq of KCl, and 2 g of MgSO(4)) at a rate of 1 mL/kg/h for 10 hours preoperatively and until the removal of the aortic cross‐clamp
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (half saline solution as placebo with an equivalent infusion rate)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: GIK infusion
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66
Study: 20299348

Group type: EXPERIMENTAL
Intervention: 1% Aquafol
Number of subjects: 288

Group type: COMPARATOR
Intervention: 1% Diprivan
Number of subjects: 288
Study: 19023947

Group type: EXPERIMENTAL
Intervention: ProDisc C disc prosthesis
Number of subjects: 49

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 49
Study: 15817582

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily
Number of subjects: 374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study: 12036648

Group type: EXPERIMENTAL
Intervention: Ropivacaine 1%-lidocaine 2% (Group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bupivacaine 0.5%-lidocaine 2% (Group 2)
Number of subjects: 80
Study: 10438982

Group type: EXPERIMENTAL
Intervention: Blastocyst transfer (group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Day 3 ET (group A)
Number of subjects: 0
Study: 7786704

Group type: EXPERIMENTAL
Intervention: Intraoperative intra-arterial fibrinolytic therapy (IIFT) with 250,000 IU of urokinase over 30 minutes
Number of subjects: 66

Group type: COMPARATOR
Intervention: Mechanical thromboembolectomy alone
Number of subjects: 66
Study: 2392793

Group type: EXPERIMENTAL
Intervention: Pressurised metered dose inhaler (400 micrograms salbutamol)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dry powder inhaler (400 micrograms salbutamol)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nebuliser (400 micrograms salbutamol)
Number of subjects: 9
Study: 507163

Group type: EXPERIMENTAL
Intervention: 4% pilocarpine hydrochloride gel applied at bedtime
Number of subjects: 15

Group type: COMPARATOR
Intervention: 4% pilocarpine hydrochloride drops instilled four times daily
Number of subjects: 15
Study: 30661908

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-based foaming handwash
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Para-chloro-meta-xylenol foaming handwash
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bland soap (control)
Number of subjects: 0
Study: 27858962

Group type: EXPERIMENTAL
Intervention: DBT skills training (n = 42)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Waitlist (WL) (n = 42)
Number of subjects: 84
Study: 27272805

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery (RS)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Open laparotomy (LT)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LS)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109
Study: 24810873

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22904177

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 19403473

Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin ointment treatment and sodium hypochlorite (bleach) baths
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intranasal petrolatum ointment treatment and plain water baths (placebo)
Number of subjects: 31
Study: 17502459

Group type: EXPERIMENTAL
Intervention: Nanoparticular CoQ(10) (100 mg 3 times a day) for 3 months
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 17181889

Group type: EXPERIMENTAL
Intervention: NaFeEDTA capsule containing 60 mg Fe once per week for IDs and IDE groups, three times per week for IDA group for nine consecutive weeks
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: NaFeEDTA capsule containing 60 mg Fe
Number of subjects: 1006
Study: 11890101

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1,200 mg daily for 11 months)
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea (DGT) (5 mg daily for 12 months)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Placebo (for 11 months in calcium group and 12 months in DGT group)
Number of subjects: 778
Study: 10434169

Group type: EXPERIMENTAL
Intervention: Ventilation at 10 breaths min‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ventilation at 20 breaths min‐1
Number of subjects: 0
Study: 7874570

Group type: EXPERIMENTAL
Intervention: nIFN‐alpha alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: nIFN‐alpha/nIFN‐gamma
Number of subjects: 16

Group type: COMPARATOR
Intervention: nIFN‐gamma alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: nIFN‐alpha/nIFN‐gamma to lymph node metastases
Number of subjects: 16

Group type: COMPARATOR
Intervention: nIFN‐alpha and nIFN‐gamma (systemic effects)
Number of subjects: 16
Study: 1973969

Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy - continuous oestradiol 17‐beta 0.05 mg daily, with norethisterone acetate 0.25 mg daily for 14 of each 28 days
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Oral hormone replacement therapy - continuous conjugated equine oestrogens 0.625 mg daily, with dl‐norgestrel 0.15 mg daily for 12 of each 28 days
Number of subjects: 66

Group type: COMPARATOR
Intervention: Untreated reference group
Number of subjects: 66
Study: 1014769

Group type: EXPERIMENTAL
Intervention: Hyoscine‐N‐butyl‐bromide (HBB) sugar‐coated tablets (5 X 20 mg/daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31512226

Group type: EXPERIMENTAL
Intervention: Ultra-mild body wash with lipids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultra-mild body wash with lipids and zinc pyrithione
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mild synthetic bar
Number of subjects: 0
Study: 31146788

Group type: EXPERIMENTAL
Intervention: BASIS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control
Number of subjects: 25
Study: 28548587

Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: TACE combined with apatinib
Number of subjects: 44
Study: 25479022

Group type: EXPERIMENTAL
Intervention: Perindopril 3.5 mg/amlodipine 2.5 mg
Number of subjects: 1581

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 1581

Group type: COMPARATOR
Intervention: Perindopril 3.5 mg
Number of subjects: 1581

Group type: COMPARATOR
Intervention: Amlodipine 2.5 mg
Number of subjects: 1581
Study: 23771796

Group type: EXPERIMENTAL
Intervention: 3-month lifestyle intervention (low-energy diet, physical activity)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (70 non-obese children)
Number of subjects: 100
Study: 21456305

Group type: EXPERIMENTAL
Intervention: Daily oral iron supplement (200 mg ferrous sulfate) for two months
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 37
Study: 19639484

Group type: EXPERIMENTAL
Intervention: Brief mindfulness instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 0
Study: 15867047

Group type: EXPERIMENTAL
Intervention: Morphine infusions
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Morphine doses before intubation and at 25 to 72 hours
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Morphine therapy
Number of subjects: 898

Group type: EXPERIMENTAL
Intervention: Preexisting hypotension
Number of subjects: 898
Study: 10326317

Group type: EXPERIMENTAL
Intervention: Rocking bed therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard bed
Number of subjects: 14
Study: 7549814

Group type: EXPERIMENTAL
Intervention: Lowering fat consumption to 20% of daily calories
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 1790545

Group type: EXPERIMENTAL
Intervention: Trimethoprim and rifampin (TMP/R) 20 mg/kg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ampicillin (AMP) 150 mg/kg/day
Number of subjects: 60
Study: 6891153

Group type: EXPERIMENTAL
Intervention: Fenoterol 2 micrograms/min
Number of subjects: 30
Study: 31287890

Group type: EXPERIMENTAL
Intervention: Oat hulls inclusion (3%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-hatch egg weight (increased from 47.0 to 54.0 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oat hulls inclusion (0%)
Number of subjects: 0
Study: 28412230

Group type: EXPERIMENTAL
Intervention: Standard care plus a multi-modal oral health promotion program (Oral Health 4 Life) integrated within the quitline services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard quitline care
Number of subjects: 0
Study: 27068858

Group type: EXPERIMENTAL
Intervention: Pazopanib plus best supportive care
Number of subjects: 81

Group type: COMPARATOR
Intervention: Best supportive care alone
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Pazopanib (after switch from best supportive care)
Number of subjects: 81
Study: 25432467

Group type: EXPERIMENTAL
Intervention: Technology-assisted, home-based, remote monitored exercise-based cardiac rehabilitation (REMOTE) for 12 weeks
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard supervised exercise-based cardiac rehabilitation for 8-12 weeks
Number of subjects: 162
Study: 21708838

Group type: EXPERIMENTAL
Intervention: 0.40 g/kg of alcohol
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0.00 g/kg (placebo)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.13 g/kg of alcohol
Number of subjects: 72
Study: 19246474

Group type: EXPERIMENTAL
Intervention: 4 mg of reboxetine (selective NE reuptake inhibitor)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 18085914

Group type: EXPERIMENTAL
Intervention: ST plus a maximum of $585 in contingent vouchers
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: ST plus an expected average maximum of $300 in contingent prizes
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard treatment (ST)
Number of subjects: 74
Study: 14730663

Group type: EXPERIMENTAL
Intervention: Redesigned mask (RD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard mask (SM)
Number of subjects: 20
Study: 11488999

Group type: EXPERIMENTAL
Intervention: Paclitaxel-cisplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel-carboplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nedaplatin
Number of subjects: 0
Study: 9428558

Group type: EXPERIMENTAL
Intervention: Head trauma group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 7851857

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 57
Study: 29698742

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Resistance Training combined with protein and vitamin supplementation (RTS)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 117
Study: 29121882

Group type: EXPERIMENTAL
Intervention: Balancing Everyday Life (BEL) program
Number of subjects: 226

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 226
Study: 26209030

Group type: EXPERIMENTAL
Intervention: Laparoscopic lavage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sigmoidectomy
Number of subjects: 90
Study: 23732247

Group type: EXPERIMENTAL
Intervention: Combined individual and telephone counselling
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Individual counselling
Number of subjects: 600

Group type: COMPARATOR
Intervention: Telephone counselling
Number of subjects: 600
Study: 21352881

Group type: EXPERIMENTAL
Intervention: Real tDCS (20-min session, anode over right prefrontal cortex, cathode over left prefrontal cortex)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 19
Study: 19699148

Group type: COMPARATOR
Intervention: therapeutic CPAP (tCPAP) after one treatment night
Number of subjects: 52

Group type: COMPARATOR
Intervention: 3 weeks of therapeutic CPAP (tCPAP)
Number of subjects: 52
Study: 17378102

Group type: EXPERIMENTAL
Intervention: Planning conference where midwives reported new mothers to a doctor (intervention group)
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Standard care with routine consultation with the doctor (control group)
Number of subjects: 1700
Study: 15499546

Group type: EXPERIMENTAL
Intervention: Infected breast milk cells (BMCs) per million cells
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Infected BMCs per milliliter
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Log10 increase in infected BMCs per milliliter
Number of subjects: 291
Study: 11563806

Group type: EXPERIMENTAL
Intervention: Low-Intensity (LI) group: 8 weeks of NRT and 1 advice and education session with a nurse practitioner (NP)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity (MI) group: NRT and 4 advice and education sessions with an NP
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) group: NRT, 4 advice and education sessions, and 12 weeks of individualized cognitive-behavioral therapy
Number of subjects: 240
Study: 9783558

Group type: EXPERIMENTAL
Intervention: Morning light (approximately 6000 lux)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Evening light (approximately 6000 lux)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Morning placebo (sham negative-ion generators)
Number of subjects: 96
Study: 7869999

Group type: EXPERIMENTAL
Intervention: Psyllium seeds (3 times 3.25 g daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wheat bran (3 times 7 g daily)
Number of subjects: 30
Study: 2971403

Group type: EXPERIMENTAL
Intervention: Clodronate (Cl2MDP) 1.6 g/day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 30760190

Group type: EXPERIMENTAL
Intervention: Treg cells (CD4+CD25+FoxP3+)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Activated CD4+ and CD8+ T cells (CD38+ HLADR+)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Treg cells
Number of subjects: 92
Study: 29691562

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Group A)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Fluoride foam (Group B)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 600
Study: 23649222

Group type: EXPERIMENTAL
Intervention: Content Acquisition Podcasts (CAPs) with explicit instructional methodology and keyword mnemonic strategy
Number of subjects: 279

Group type: COMPARATOR
Intervention: Multimedia instruction without a specific theoretical design framework
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: General education students receiving CAPs
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Satisfaction measure following multimedia instruction
Number of subjects: 279
Study: 24075051

Group type: EXPERIMENTAL
Intervention: ASC-enriched fat grafts (20×10^6 cells per mL fat)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control grafts (non-enriched fat grafts)
Number of subjects: 10
Study: 21411557

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg s.c. every 6 months)
Number of subjects: 7808
Study: 19146606

Group type: EXPERIMENTAL
Intervention: Topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 10
Study: 16831410

Group type: EXPERIMENTAL
Intervention: Radiotherapy and selenium supplementation (400 mug/day for 6 months)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 63
Study: 14636464

Group type: EXPERIMENTAL
Intervention: Adenosine (3, 6, and 12 mg intravenous bolus doses)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Verapamil (5 mg or additional 5 mg intravenously)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 122
Study: 11112865

Group type: EXPERIMENTAL
Intervention: hcfHrp (BTA STAT(TM))
Number of subjects: 354
Study: 8854770

Group type: EXPERIMENTAL
Intervention: High-dose intraarterial chemotherapy with percutaneous hepatic venous isolation and charcoal hemoperfusion (HVI.CHP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional intraarterial chemotherapy (group S)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Transarterial embolization (TAE; group T)
Number of subjects: 38
Study: 1615378

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.03 mg/kg/h
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.08 mg/kg/h
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.11 mg/kg/h
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine 0.15 mg/kg/h
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Oral nicardipine 90‐120 mg
Number of subjects: 52
Study: 6380436

Group type: EXPERIMENTAL
Intervention: Transfer factor (1 ml extracted from the blood of normal individuals, administered starting 1 month postoperatively and at 3-month intervals)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no transfer factor treatment)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 31492430

Group type: EXPERIMENTAL
Intervention: 12-week weight loss program followed by 4-week weight stabilization
Number of subjects: 42

Group type: COMPARATOR
Intervention: 16-week weight maintenance program
Number of subjects: 42
Study: 29498885

Group type: EXPERIMENTAL
Intervention: Surgical excision of the macroscopically degenerated portion of the ECRB (n = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham surgery (skin incision and exposure of the ECRB alone; n = 13)
Number of subjects: 26
Study: 27642077

Group type: EXPERIMENTAL
Intervention: SSRI (citalopram, 40mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: NK1R antagonist (GR205171, 5mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24290749

Group type: EXPERIMENTAL
Intervention: Percutaneous hepatic perfusion (PHP) with venovenous bypass circuit and hemofiltration, receiving hepatic intra-arterial melphalan, 3 mg/kg for 30 minutes with 60 minutes of hemofiltration
Number of subjects: 5

Group type: COMPARATOR
Intervention: Best alternative care (BAC)
Number of subjects: 5
Study: 21283045

Group type: EXPERIMENTAL
Intervention: Closed-system suctioning
Number of subjects: 250

Group type: COMPARATOR
Intervention: Open endotracheal suctioning
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Patients with ventilator-associated pneumonia
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Patients without ventilator-associated pneumonia
Number of subjects: 250
Study: 20674364

Group type: EXPERIMENTAL
Intervention: Non-paretic leg constraint by a step
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal seat height (100% of knee height)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Elevated seat height (130% of knee height)
Number of subjects: 13
Study: 17462454

Group type: EXPERIMENTAL
Intervention: Preoperative and perioperative blood conservation interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antifibrinolytic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cell-saving device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multimodality blood conservation program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythropoietin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative blood salvage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Autologous predonation and normovolemic hemodilution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consensus, institution-specific blood transfusion algorithms
Number of subjects: 0
Study: 15060495

Group type: EXPERIMENTAL
Intervention: Simulated pulpal pressure with Superbond C&B adhesive luting agent
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Simulated pulpal pressure with polycarboxylate luting cement (Poly-F Plus)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No simulated pulpal pressure with Superbond C&B adhesive luting agent
Number of subjects: 48

Group type: COMPARATOR
Intervention: No simulated pulpal pressure with polycarboxylate luting cement (Poly-F Plus)
Number of subjects: 48
Study: 11521696

Group type: EXPERIMENTAL
Intervention: Short-term topical prednisolone acetate 1% (0-6 months)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Long-term topical prednisolone acetate 1% (0-12 months)
Number of subjects: 136
Study: 9988360

Group type: EXPERIMENTAL
Intervention: CATS‐Fresenius
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sequestra 1000‐Medtronic
Number of subjects: 27

Group type: COMPARATOR
Intervention: Blood products from institutional blood bank
Number of subjects: 27
Study: 7921461

Group type: EXPERIMENTAL
Intervention: Biphasic CPAP
Number of subjects: 19

Group type: COMPARATOR
Intervention: Assisted Spontaneous Breathing (ASB)
Number of subjects: 19
Study: 3260795

Group type: EXPERIMENTAL
Intervention: Subarachnoid block and light general anaesthesia
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional general anaesthesia with intermittent positive pressure ventilation
Number of subjects: 98
Study: 30341095

Group type: EXPERIMENTAL
Intervention: Folic acid (400 μg) and vitamin B12 (500 μg) supplementation
Number of subjects: 2524

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2524
Study: 30082325

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 1791

Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 1791

Group type: EXPERIMENTAL
Intervention: HbA1c measures
Number of subjects: 1791
Study: 26813674

Group type: EXPERIMENTAL
Intervention: 6-PACK programme
Number of subjects: 31411

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 31411
Study: 25168768

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of tetanus-diphtheria vaccine
Number of subjects: 230

Group type: COMPARATOR
Intervention: Subcutaneous injection of tetanus-diphtheria vaccine
Number of subjects: 230